|C8 Study Publications|
This list of scientific publications about PFOA and other PFAS, by the three members of the C8 Science panel was last updated in January 2020.
High exposure to perfluorinated compounds in drinking water and thyroid disease. A cohort study from Ronneby, Sweden.
Andersson EM, Scott K, Xu Y, Li Y, Olsson DS, Fletcher T, Jakobsson K.
Inflammatory bowel disease and biomarkers of gut inflammation and permeability in a community with high exposure to perfluoroalkyl substances through drinking water.
Xu Y, Li Y, Scott K, Lindh CH, Jakobsson K, Fletcher T, Ohlsson B, Andersson EM.
Evaluation and management strategies for per- and polyfluoroalkyl substances (PFASs) in drinking water aquifers: perspectives from impacted U.S. northeast communities.
Guelfo JL, Marlow T, Klein DM, Savitz DA, Frickel S, Crimi M, Suuberg EM.
Half-lives of PFOS, PFHxS and PFOA after end of exposure to contaminated drinking water.
Li Y, Fletcher T, Mucs D, Scott K, Lindh CH, Tallving P, Jakobsson K.
Zürich Statement on Future Actions on Per- and Polyfluoroalkyl Substances (PFASs).
Ritscher A, Wang Z, Scheringer M, Boucher JM, Ahrens L, Berger U, Bintein S, Bopp SK, Borg D, Buser AM, Cousins I, DeWitt J, Fletcher T, Green C, Herzke D, Higgins C, Huang J, Hung H, Knepper T, Lau CS, Leinala E, Lindstrom AB, Liu J, Miller M, Ohno K, Perkola N, Shi Y, Småstuen Haug L, Trier X, Valsecchi S, van der Jagt K, Vierke L. (2018).
When is epidemiological research a helpful response to industrial contamination?
Serum perfluorooctanoic acid and birthweight: an updated meta-analysis with bias analysis.
Steenland K, Barry V, Savitz D.
PFOA and ulcerative colitis.
Steenland K, Kugathasan S, Barr DB.
Exposure to perfluoroalkyl substances and thyroid function in pregnant women and children: A systematic review of epidemiologic studies.
Ballesteros V, Costa O, Iñiguez C, Fletcher T, Ballester F, Lopez-Espinosa MJ.
Technical Report: Half-lives of PFOS, PFHxS and PFOA after end of exposure to contaminated drinking water.
Li Y, Mucs D, Scott K, Lindh CH, Tallving P, Fletcher T, Jakobsson K.
Impact of exposure uncertainty on the association between perfluorooctanoate and preeclampsia in the C8 Health Project population.
Avanasi R, Shin HM, Vieira VM, Savitz DA, Bartell SM.
Modeled Perfluorooctanoic Acid (PFOA) Exposure and Liver Function in a Mid-Ohio Valley Community.
Darrow LA, Groth AC, Winquist A, Shin HM, Bartell SM, Steenland K.
Perfluorooctanoic acid and chronic kidney disease: Longitudinal analysis of a Mid-Ohio Valley community.
Dhingra R, Lally C, Darrow LA, Klein M, Winquist A, Steenland K.
A Study of Reverse Causation: Examining the Associations of Perfluorooctanoic Acid Serum Levels with Two Outcomes.
Dhingra R, Winquist A, Darrow LA, Klein M, Steenland K.
Environmental Health Perspectives EHP273. Epub 2016 Aug 16. PubMed PMID: 27529882; PubMed Central PMCID: PMC5332181.
Perfluoroalkyl Substances, Sex Hormones, and Insulin-like Growth Factor-1 at 6-9 Years of Age: A Cross-Sectional Analysis within the C8 Health Project.
Lopez-Espinosa MJ, Mondal D, Armstrong BG, Eskenazi B, Fletcher T.
The Madrid Statement on Poly- and Perfluoroalkyl Substances (PFASs).
Blum A., Balan SA, Scheringer M, Goldenman G, Trier X, Cousins IT, Diamond M, Higgins C, Avery E, Peaslee G, de Voogt P, Fletcher T, Wang Z, Weber R.
Comment on "Fluorotechnology Is Critical to Modern Life: The FluoroCouncil Counterpoint to the Madrid Statement".
Cousins IT, Balan SA, Scheringer M, Weber R, Wang Z, Blum A, Diamond M, Fletcher T, Goldenman G, Higgins C, Lindeman AE, Peaslee G, Trier X, de Voogt P.
A cohort incidence study of workers exposed to perfluorooctanoic acid (PFOA).
Steenland K, Zhao L, Winquist A.
PFOA and PFOS are associated with reduced expression of the parathyroid hormone 2 receptor (PTH2R) gene in women.
Tamara S. Galloway, Tony Fletcher, Oliver J. Thomas, Ben P. Lee, Luke C. Pilling, Lorna W. Harries.
Early life perfluorooctanoic acid (PFOA) exposure and overweight and obesity risk in adulthood in a community with elevated exposure.
Barry V, Darrow LA, Klein M, Winquist A, Steenland K.
PFOA and PFOS serum levels and miscarriage risk.
Darrow LA, Howards PP, Winquist A, Steenland K.
Incidence of type II diabetes in a cohort with substantial exposure to perfluorooctanoic acid.
Karnes C, Winquist A, Steenland K.
Helsingør statement on poly- and perfluorinated alkyl substances (PFASs).
Scheringer M, Trier X, Cousins IT, de Voogt P, Fletcher T, Wang Z, Webster TF.
Biomarker-based calibration of retrospective exposure predictions of perfluorooctanoic acid.
Shin HM, Steenland K, Ryan PB, Vieira VM, Bartell SM.
Commentary: Class Action Lawsuits: Can They Advance Epidemiologic Research?
Steenland, K, Savitz, DA, Fletcher, T.
Perfluorooctanoate Exposure and Major Birth Defects.
Stein CR, Savitz DA, Elston B, Thorpe PG, Gilboa SM.
Modeled PFOA exposure and coronary artery disease, hypertension, and high cholesterol in community and worker cohorts.
Winquist A, Steenland K.
Perfluorooctanoic acid exposure and thyroid disease in community and worker cohorts.
Winquist A, Steenland K.
Associations Between Serum Perfluoroalkyl Acids and LINE-1 DNA Methylation.
Watkins DJ, Wellenius GA, Butler RA, Bartell SM, Fletcher T, Kelsey KT.
Influenza vaccine response in adults exposed to perfluorooctanoate (PFOA) and perfluorooctanesulfonate (PFOS).
Looker C, Luster MI, Calafat AM, Johnson VJ, Burleson GR, Burleson FG, Fletcher T.
Perfluorooctanoic Acid (PFOA) Exposures and Incident Cancers Among Adults Living Near a Chemical Plant.
Barry V, Winquist A, Steenland K.
Serum Perfluorooctanoic Acid and Perfluorooctane Sulfonate Concentrations in Relation to Birth Outcomes in the Mid-Ohio Valley, 2005-2010.
Darrow LA, Stein CR, Steenland K.
Design, methods, and population for a study of PFOA health effects among highly exposed Mid-Ohio Valley community residents and workers.
Winquist A, Lally C, Shin HM, Steenland K.
Ulcerative colitis and perfluorooctanoic acid (PFOA) in a highly exposed population of community residents and workers in the Mid-Ohio Valley.
Steenland K, Zhao L, Winquist A, Parks C.
Assessing the Spatial Distribution of Perfluorooctanoic Acid Exposure via Public Drinking Water Pipes Using Geographic Information Systems.
Vieira V, Hoffman K, Fletcher T.
Reductions in serum lipids with a 4-year decline in serum perfluorooctanoic acid and perfluorooctanesulfonic acid.
Fitz-Simon N, Fletcher T, Luster MI, Steenland K, Calafat AM, Kato K, Armstrong B.
Associations between PFOA, PFOS and changes in the expression of genes involved in cholesterol metabolism in humans.
Fletcher T, Galloway TS, Melzer D, Holcroft P, Cipelli R, Pilling LC, Mondal D, Luster M, Harries LW.
Perfluorooctanoate and neuropsychological outcomes in children.
Stein CR, Savitz DA, Bellinger DC.
Serum perfluoroalkyl acids concentrations and memory impairment in a large cross-sectional study.
Gallo V, Leonardi G, Brayne C, Armstrong B, Fletcher T.
Exposure to perfluoroalkyl acids and markers of kidney function among children and adolescents living near a chemical plant.
Watkins DJ, Josson J, Elston B, Bartell SM, Shin HM, Vieira VM, Savitz DA, Fletcher T, Wellenius GA.
Perfluorooctanoic acid exposure and cancer outcomes in a contaminated community: a geographic analysis.
Vieira VM, Hoffman K, Shin HM, Weinberg JM, Webster TF, Fletcher T.
Cohort mortality study of workers exposed to perfluorooctanoic acid.
Steenland K, Woskie S.
Retrospective exposure assessment of perfluorooctanoic acid serum concentrations at a fluoropolymer manufacturing plant.
Woskie SR, Gore R, Steenland K.
Modeling the air-soil transport pathway of perfluorooctanoic acid in the Mid-Ohio Valley using linked air dispersion and vadose zone models
Shin HM, Ryan PB, Vieira VM, Bartell SM.
Perfluorooctanoic Acid exposure and pregnancy outcome in a highly exposed community
Savitz DA, Stein CR, Bartell SM, Elston B, Gong J, Shin H-M, Wellenius GA.
Thyroid Function and Perfluoroalkyl Acids in Children Living Near a Chemical Plant
Lopez-Espinosa M-J, Mondal D, Armstrong B, Bloom MS, Fletcher T.
Relationship of Perfluorooctanoic Acid Exposure to Pregnancy Outcome Based on Birth Records in the Mid-Ohio Valley
Savitz DA, Stein CR, Elston B, Wellenius GA, Bartell SM, Shin H-M, Vieira VM, Fletcher T.
Modeling the air-soil transport pathway of perfluorooctanoic acid in the mid-Ohio Valley using linked air dispersion and vadose zone models
Shin H-M, Ryan PB, Vieira VM, Bartell SM.
Serum Perfluorooctanoate (PFOA) and Perfluorooctane Sulfonate (PFOS) Concentrations and Liver Function Biomarkers in a Population with Elevated PFOA Exposure
Gallo V, Leonardi G, Genser B, Lopez-Espinosa M-J, Frisbee SJ, Karlsson L, Ducatman AM, Fletcher T.
Relationships of Perfluorooctanoate and Perfluorooctane Sulfonate Serum Concentrations Between Child-Mother Pairs in a Population with Perfluorooctanoate Exposure from Drinking Water
Mondal D, Lopez-Espinosa M-J, Armstrong B, Stein CR, Fletcher T.
Retrospective exposure estimation and predicted versus observed serum perfluorooctanoic acid concentrations for participants in the C8 Health Project
Shin H-M, Vieira VM, Ryan PB, Steenland K, Bartell SM.
Serum Perfluorinated Compound Concentration and Attention Deficit/Hyperactivity Disorder in Children 5-18 Years of Age
Stein CR, Savitz DA.
Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with age of puberty among children living near a chemical plant.
Lopez-Espinosa M-J, Fletcher T, Armstrong B, Genser B, Dhatariya K, Mondal D, Ducatman A, Leonardi G.
Comparison between free serum thyroxine levels, measured by analog and dialysis methods, in the presence of perfluorooctane sulfonate and perfluorooctanoate.
Lopez-Espinosa M-J, Fitz-Simon N, Bloom MS, Calafat AM, Fletcher T.
Environmental fate and transport modeling for perfluorooctanoic acid emitted from the Washington Works Facility in West Virginia.
Shin H-M, Vieira VM, Ryan PB, Detwiler R, Sanders B, Steenland K, Bartell SM.
Private drinking water wells as a source of exposure to PFOA in communities surrounding a fluoropolymer production facility.
Hoffman K, Webster TF, Bartell SM, Weisskopf MG, Fletcher T, Vieira VM.
Accumulation and clearance of PFOA in current and former residents of an exposed community.
Seals R, Bartell SM, Steenland K.
Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: Results from the C8 Health Project.
Frisbee SJ, Shankar A, Knox SS, Steenland K, Savitz DA, Fletcher T, Ducatman AM.
Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA).
Steenland K, Fletcher T, Savitz DA.
Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with uric acid among adults with elevated community exposure to PFOA.
Steenland K, Tinker S, Shankar A, Ducatman A.
Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia.
Bartell SM, Calafat AM, Lyu C, Kato K, Ryan PB, Steenland K.
The C8 Health Project: Design, methods, and participants.
Frisbee SJ, Brooks AP Jr, Maher A, Flensborg P, Arnold S, Fletcher T, Steenland K, Shankar A, Knox SS, Pollard C, Halverson JA, Vieira VM, Jin C, Leyden KM, Ducatman AM.
A cross-sectional analysis of type II diabetes in a community with exposure to perfluorooctanoic acid (PFOA).
MacNeil J, Steenland NK, Shankar A, Ducatman A.
Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant.
Steenland K, Tinker S, Frisbee S, Ducatman A, Vaccarino V.
Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome.
Stein CR, Savitz DA, Dougan M.
Predictors of PFOA levels in a community surrounding a chemical plant.
Steenland K, Jin C, MacNeil J, Lally C, Ducatman A, Vieira V, Fletcher T.
Note on accessing the full articles: for some of the above articles only the abstract is available online. This means that a photocopy or an online pdf document version of the full text of the article can only be obtained from the authors, from someone who has (or a library which has) subscribed to the journal, or by paying online to the journal.